Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
New FDA-approved TIL therapy uses patients' immune cells to combat advanced melanoma effectively.
A new FDA-approved treatment for advanced melanoma, called Tumor-Infiltrating-Lymphocyte (TIL) therapy, uses a patient's own tumor and immune cells to fight the disease.
The treatment, a second or third option for patients, has shown promise in cases like Schneider's, where it helped him recover from stage four melanoma and return to normal life.
Experts believe this therapy could also treat other cancers in the future.
5 Articles
La nueva terapia TIL aprobada por la FDA utiliza las células inmunes de los pacientes para combatir el melanoma avanzado con eficacia.